Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks (SUNHA): results from an open-label phase Ib ascending dose study (Headache, September 2024)
Links to other websites do not imply affiliation or endorsement. Beckley Psytech does not control and is not responsible for their content.
